Molecular Imaging in Ischemic Heart Disease.
I Theodoulou, I Rashid, R Hajhosseiny… - Current …, 2019 - europepmc.org
… cardiac molecular imaging, positron emission tomography (PET) and … and revascularization
directly determines the extent of … The tracer 18 F-galacto-RGD has been successfully used to …
directly determines the extent of … The tracer 18 F-galacto-RGD has been successfully used to …
Novel Positron-Emitting Radiopharmaceuticals
O Keinänen, AG Nash, SM Sarrett… - Nuclear Oncology: From …, 2022 - Springer
… Both positron emission tomography (PET) and single photon … an 18F-labeled prosthetic
group to galacto-RGD to form [18F] … same patients, [18F]FDG and CT only identified 10 and 13 …
group to galacto-RGD to form [18F] … same patients, [18F]FDG and CT only identified 10 and 13 …
Application of a new 68Ga-labeled cNGR dimer peptide to microPET imaging of ovarian cancer
Y Yang, J Zhang, H Zou, Y Shen, Y Wu - 2020 - researchsquare.com
… to identify tumors with CD13 expression at different levels. … imaging of alpha(v)beta3
integrin expression using 18F-labeled … ) Positron emission tomography using [18F]Galacto-RGD …
integrin expression using 18F-labeled … ) Positron emission tomography using [18F]Galacto-RGD …
[HTML][HTML] Multimodal and multiscale analysis reveals distinct vascular, metabolic and inflammatory components of the tissue response to limb ischemia
T Kapanadze, JP Bankstahl, A Wittneben… - Theranostics, 2019 - ncbi.nlm.nih.gov
… , and glucose uptake studies identified macrophages as major … emission tomography (PET)
combined with x-ray based … other integrin subtypes, such as α V β 5 and α V β 1 , expressed …
combined with x-ray based … other integrin subtypes, such as α V β 5 and α V β 1 , expressed …
Investigational PET tracers in neuro-oncology-Whats on the horizon? A report of the PET/RANO group.
R Soffietti, P Wen, M Weller, J Tonn, N Galldiks… - Neuro …, 2022 - escholarship.org
… help to identify potentially druggable targets (eg, integrins in … integrin alpha(v)beta(3)
expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography…
expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography…
Radionuclide Imaging
… -emission tomography (PET)/CT has begun to offer … a significant increase in αvβ3 integrin
expression within muscle sampled … of inflammation within atherosclerotic plaques and identify …
expression within muscle sampled … of inflammation within atherosclerotic plaques and identify …
Molecular Imaging of Vulnerable Plaque
R Laudicella, K Christel, IA Burger, S Baldari… - Imaging of Inflammation …, 2021 - Springer
… In this setting, 68Ga-Pentixafor PET/CT identified a broad … Positron emission tomography
(PET) using different … (20 min)/reperfusion using 18F-galacto- RGD. (a) Autoradiographic …
(PET) using different … (20 min)/reperfusion using 18F-galacto- RGD. (a) Autoradiographic …
[HTML][HTML] PET/CT in pediatric oncology
G Masselli, C De Angelis, S Sollaku… - American Journal of …, 2020 - ncbi.nlm.nih.gov
… PET/CT (Positron Emission Tomography/Computed Tomography) … Furthermore, the evaluation
of SSTRs expression in patients … as it defines the correct treatment for each stage (Stage I …
of SSTRs expression in patients … as it defines the correct treatment for each stage (Stage I …
Nanotheranostics-based imaging for cancer treatment monitoring
… as positron-emission tomography (PET) and single-photon … characterize the tumor masses,
identify stage, and even noninvasively … F-Galacto-RGD was the first published RGD peptide …
identify stage, and even noninvasively … F-Galacto-RGD was the first published RGD peptide …
[PDF][PDF] Rohini Sharma1 & Pablo Oriol Valls1 & Marianna Inglese1, 2 & Suraiya Dubash1 & Michelle Chen1 & Hani Gabra1, 3 & Ana Montes4 & Amarnath Challapalli5 …
JP Lozano-Kuehne, TD Barwick, EO Aboagye - 2019 - d-nb.info
… [18F]Galacto-RGD positron emission tomography for imaging of … identifies the level of
integrin alpha(v)beta3 expression in man. Clin Cancer Res. 2006;12(13):3942–9. …
integrin alpha(v)beta3 expression in man. Clin Cancer Res. 2006;12(13):3942–9. …